8
Participants
Start Date
September 30, 2008
Primary Completion Date
November 30, 2008
Study Completion Date
December 31, 2008
Aricept (donepezil hydrochloride)
All participants will start with a dose of 2.5 mg/day (2.5 ml) donepezil ; dose escalation will occur every 2 weeks to a maximum of 5 mg/day (5 ml) donepezil. All doses will be administered orally.
Aricept (donepezil hydrochloride)
All participants will start with a dose of 2.5 mg/day (2.5 ml) donepezil ; dose escalations will occur every 2 weeks to a maximum of 10 mg/day (10 ml) donepezil. All doses will be administered orally.
Placebo
All participants will start with a dose of 2.5 mg/day (2.5 ml) placebo; dose escalations will occur every 2 weeks to a maximum of 10 mg/day (10 ml) placebo. All doses will be administered orally.
Neuroscience, Inc, Herndon
Road Runner Research, San Antonio
Collaborators (1)
Pfizer
INDUSTRY
Eisai Inc.
INDUSTRY